Risk governance of stem cells as therapeutic products (2007)
Attributed to:
ESRC Centre for Social and Economic Research on Innovation in Genomics (Innogen)
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Type: Working Paper